Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02577822 · ClinicalTrials.gov registry record · NA
The Viability of Short Stems in Total Hip Arthroplasty
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02577822 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 60 participants.
The verdict
NCT02577822, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the viability of short femoral stems as an alternative to standard-length stems in total hip arthroplasty.
Interventions
- DEVICE Taperloc standard length stem
- DEVICE Taperloc short length stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-10 |
| Est. Completion | 2019-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02577822
The ClinicalTrials.gov registry entry for NCT02577822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Taperloc standard length stem is the first listed.
NCT02577822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02577822 about?
NCT02577822 is a clinical study titled "The Viability of Short Stems in Total Hip Arthroplasty". The purpose of this study is to determine the viability of short femoral stems as an alternative to standard-length stems in total hip arthroplasty.
What is the current status of trial NCT02577822?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-10. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02577822?
The interventions under investigation include: Taperloc standard length stem (DEVICE), Taperloc short length stem (DEVICE).
Who is sponsoring clinical trial NCT02577822?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.